You are here

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist

 

Online download statistics by month:

Online download statistics by month: April 2020 to July 2025

AbstractFullPdf
Apr 2020417417387
May 2020339339162
Jun 202013413448
Jul 2020727253
Aug 2020535364
Sep 2020707056
Oct 2020383836
Nov 2020555547
Dec 2020686849
Jan 2021777745
Feb 202110010056
Mar 202112312381
Apr 202112812869
May 202110510565
Jun 2021818158
Jul 202110710751
Aug 2021596046
Sep 2021868639
Oct 2021878779
Nov 202110010060
Dec 2021797949
Jan 202214815456
Feb 2022889056
Mar 202211511557
Apr 2022909752
May 20229810358
Jun 2022798361
Jul 20229010257
Aug 2022869371
Sep 20228484262
Oct 2022717251
Nov 2022777950
Dec 2022636338
Jan 2023767639
Feb 2023969728
Mar 2023626324
Apr 2023393926
May 2023474724
Jun 2023545429
Jul 2023717125
Aug 2023363624
Sep 2023353522
Oct 2023596029
Nov 2023787821
Dec 2023777740
Jan 2024464729
Feb 2024464624
Mar 2024717254
Apr 2024697050
May 202413213239
Jun 2024585831
Jul 2024616323
Aug 202410310018
Sep 2024535330
Oct 20244849144
Nov 2024969734
Dec 2024848728
Jan 2025939325
Feb 202515415425
Mar 2025888830
Apr 202510610725
May 2025505024
Jun 2025363616
Jul 2025110
Total559256503449